A strong case for third-party testing

Fridtjof Lund-Johansen1

  • 1Department of Immunology, Oslo University Hospital, Oslo, Norway.

Elife
|November 14, 2023
PubMed

A strategy to identify high-quality commercially available antibodies for research reveals extensive use of non-specific antibodies and offers solutions for future large-scale testing.